Addex Therapeutics Ltd (ADXN)
7.63
+0.25
(+3.39%)
USD |
NASDAQ |
Nov 21, 14:50
Addex Therapeutics Price: 7.63 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 7.82 | 7.82 | 7.33 | 7.38 | 10938.00 |
| Nov 19, 2024 | 7.81 | 8.25 | 7.76 | 7.97 | 51769.00 |
| Nov 18, 2024 | 8.01 | 8.23 | 7.39 | 7.91 | 81366.00 |
| Nov 15, 2024 | 8.04 | 8.33 | 7.70 | 8.06 | 21164.00 |
| Nov 14, 2024 | 8.68 | 8.77 | 7.86 | 8.20 | 106429.0 |
| Nov 13, 2024 | 9.26 | 9.890 | 8.59 | 8.63 | 129738.0 |
| Nov 12, 2024 | 8.84 | 9.26 | 8.36 | 8.77 | 114403.0 |
| Nov 11, 2024 | 11.01 | 11.68 | 10.45 | 10.78 | 132797.0 |
| Nov 08, 2024 | 10.91 | 11.40 | 10.54 | 10.55 | 17804.00 |
| Nov 07, 2024 | 10.97 | 11.76 | 10.64 | 10.64 | 23685.00 |
| Nov 06, 2024 | 11.08 | 11.80 | 10.91 | 11.01 | 105404.0 |
| Nov 05, 2024 | 11.26 | 11.70 | 10.40 | 11.08 | 123036.0 |
| Nov 04, 2024 | 10.65 | 11.39 | 10.65 | 10.96 | 53418.00 |
| Nov 01, 2024 | 10.76 | 11.11 | 10.55 | 10.70 | 16815.00 |
| Oct 31, 2024 | 10.72 | 10.72 | 9.73 | 9.75 | 32897.00 |
| Oct 30, 2024 | 10.54 | 11.80 | 10.44 | 10.72 | 49604.00 |
| Oct 29, 2024 | 10.80 | 11.00 | 10.09 | 10.41 | 32277.00 |
| Oct 28, 2024 | 11.26 | 11.65 | 11.01 | 11.01 | 28555.00 |
| Oct 25, 2024 | 11.50 | 11.74 | 10.59 | 11.01 | 16935.00 |
| Oct 24, 2024 | 11.71 | 11.84 | 11.31 | 11.56 | 14439.00 |
| Oct 23, 2024 | 11.31 | 11.35 | 10.86 | 10.86 | 5516.00 |
| Oct 22, 2024 | 11.21 | 11.65 | 10.67 | 10.67 | 67655.00 |
| Oct 21, 2024 | 10.89 | 10.90 | 10.18 | 10.30 | 41907.00 |
| Oct 18, 2024 | 10.38 | 10.61 | 10.04 | 10.44 | 18920.00 |
| Oct 17, 2024 | 10.46 | 10.60 | 10.44 | 10.60 | 8604.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.15
Minimum
Dec 18 2023
483.80
Maximum
Dec 24 2020
96.15
Average
36.60
Median
Mar 03 2023
Price Benchmarks
| AC Immune SA | 3.24 |
| CRISPR Therapeutics AG | 46.26 |
| NLS Pharmaceutics Ltd | 3.31 |
| Molecular Partners AG | 5.34 |
| MoonLake Immunotherapeutics | 52.07 |
Price Related Metrics
| PS Ratio | 7.266 |
| Price to Book Value | 0.5794 |
| Earnings Yield | -21.53% |
| Market Cap | 8.154M |